International - Doctors, Hospitals, Medical in South Africa, Cape Town

advertisement

International

2009 1. Invited talk. Advanced breast cancer, uterine sarcoma, irresectable neck nodes and maxillary sinus tumours treated with neutron therapy.

C. Stannard, E. Murray, L. v Wijk, M. Maurel, P. Kraus, F. Vernimmen,

S. Fredericks, S. De Canha. 1st Romanian Society of Hadrontherapy

Workshop, Predeal, Romania. February/March 2009

2007 2. Poster: Vandetanib with Docetaxel as second-line treatment for advanced breast cancer: a double-blind, placebo-controlled, randomized Phase II study.

K. Bo ér, I. Láng, A. Llombart-Cussac,

I. Andreasson, G.L. Vivanco, N. Sanders, G.M. Pover and E. Murray.

San Antonio Breast Cancer Symposium, December 2007.

2007 3. Invited Speaker: African Organisation for Research & Training in

Cancer (AORTIC), October 2007, Cape Town. Plenary Session:

Management of Breast Cancer in Africa

2007 4. Poster: A study to investigate the role of p27 and cyclin E immunoexpression as a prognostic factor in early breast carcinoma.

K. Pillay, R. Chetty, H. McCleod, E.M. Murray, P. Hall. Primary Therapy of

Early Breast Cancer 10 th International Conference, St. Gallen, Switzerland

March 2007

2006 5. Poster: Neutron vs photon radiotherapy in locally advanced breast cancer with or without metastases. E.M. Murray, I.D. Werner, G. Schmitt,

C. Stannard, A. Gudgeon, J. Wilson, J. Harris, S. Fredericks, E. McEvoy,

E. Nel, S. De Canha* International Workshop On Fast Neutron Therapy,

Essen, 14-16 September 2006 *presenting author

2006 6. Importance of number of examined axillary lymph nodes for assessing the risk of locoregional recurrence (LRR) among breast cancer patients with 1-3 lymph node metastases. P. Karlsson, B.F. Cole, M. Castiglione-

Gertsch, B.A. Gusterson, J. Lindtner, J.P. Collins, M. Fey, E. Murray,

A. Goldhirsch, A. Wallgren for the International Breast Cancer Study Group.

European Breast Cancer Conference, Nice, France 21-25 March 2006.

2003 7. Invited Speaker: Breast Cancer in Developing Countries. (AORTIC) IV

International Conference on Cancer in Africa: Meeting the Challenges of the

21 st Century, Accra, Ghana, 6-10 October 2003.

2003 8. Quality-adjusted survival (QAS) in patients with postmenopausal breast cancer using patient-rated utilities to extend the Q-TwiST concept.

J. Bernhard, D. Zahrieh, A. Coates, R. Gelber, M. Castiglione-Gertsch,

E. Murray , J. Forbes, L. Perey, A. Goldhirsch, C. Hürny, for the International

Breast Cancer Study Group (IBCSG). American Society of Clinical Oncology

Annual Meeting, Chicago, Illinois, United States of America, 31 May - 3 June

2003.

2002 9. Biological markers (BM) with predictive value in metastatic breast cancer (MBC) patients (PTS) randomly treated with doxorubicin (A) or docetaxel (D).

A. Di Leo, S. Chan, K Friederichs, T. Pinter, S. Van Belle,

E. Murray, I. Bodrogi, E. Walpole, B. Lesperance, S. Korec, J. Crown,

P. Simmonds, S. Dolci, D. Larsimont, N. Azli, C. Dumontet, J. Isola,

M. Paesmans, M.J. Piccart on behalf of the TAX 303 Translational Research

Study. American Society of Clinical Oncology (ASCO) Annual Meeting,

Orlando, Florida, 18-21 May 2002.

2001 10. Invited speaker: Symposium - Breast cancer in developing countries: Locally advanced breast cancer. Topic : Medical & Radiation Oncology in a developing country.

E. Murray International Surgical Week ISW2001,

Brussels, Belgium 26-30 August 2001.

1999 11. Treatment with chemotherapy alone is inadequate for very young women with estrogen receptor positive breast cancer. Results from the

International Breast Cancer Study Group (IBCSG) Trials I, II, V and VI.

S. Aevi, S. Gelber, M. Castiglione-Gertsch, R.D. Gelber, J. Collins,

B. Thurlimann, C.M.Rudenstam, J. Lindtner, A. Veronesi, H. Cortes-Funes,

E. Simoncini, E. Murray, A.S. Coates, A. Goldhirsch, for the IBCSG, Bern,

Switzerland American Society Of Clinical Oncology (ASCO) Annual Meeting,

May 1999.

1997 12. Phase II study of I.V. Navelbine (NVB) and Doxorubicin (DOX) in previously untreated advanced breast cancer (ABC). D. Vorobiof,

L. Goedhals, P. Barnardt, A. Gudgeon, A. Van Der Merwe, L. Smith,

E. Murray, D. Pretorius, P. Bassompierre, E. Bergonzoli, F.M. Delgado,

I. Lepape, J.P. Burillon, S. Le Couturier. 9th European Conference on

Clinical Oncology (ECCO9), Hamburg, Germany, 14-18 September, 1997.

1997 13 . Phase II study of I.V. Navelbine (NVB) and Doxorubicin (DOX) in previously untreated advanced breast cancer (ABC).

D. Vorobiof,

L. Goedhals, P. Barnardt, A. Gudgeon, A. Van Der Merwe, L. Smith,

E. Murray, D. Pretorius, P. Bassompierre, E. Bergonzoli, F.M. Delgado,

I. Lepape, J.P. Burillon, S. Le Couturier. American Society of Clinical

Oncology (ASCO) Annual Meeting 1997, Denver, Colorado, United States of

America, 17-20 May 1997.

1994

2009

14.

5.

Breast conservation for early breast cancer.

V. Pervan, A. Gudgeon,

I.D. Werner, E. Murray. 8th International Conference on Cancer Nursing,

Vancouver, Canada, 7-12 August 1994

1994 15. Neutron irradiation in advanced breast cancer.

E. Kwatsha, E. Murray,

A. Gudgeon, I.D. Werner 8th International Conference on Cancer Nursing,

Vancouver, Canada, 7-12 August 1994

5.2 Local

2012 1. Invited Speaker The time has come for partial breast irradiation?

E. Murray. Surgical Update Conference. University of Cape Town.

March2012

2012 2. Invited Speaker Myalgic Encephalomyelitis/Chronic Fatigue Syndrome –

Family Medicine Registrars Seminar March 2012

2012 3.

2009 4.

Session Chair ICON conference Breast Cancer Session March 2012

Beyond CAF: Chemotherapy and biological agents in breast cancer.

E. Murray. Surgical Update Congress, University of Cape Town.

March 2009

Radiotherapy and Reconstruction in Breast Cancer . E. Murray

National Plastic Surgeons Registrar Congress. University of Cape Town

2009 6.

2009 7.

2007

2006

8.

9.

2005 10.

2004 11.

2004 12.

2003 13.

2003 14.

2002 15.

2001 16.

March 2009

Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: Combined results of 15 International Breast Cancer

Study group clinical trials. B.C. Pestalozzi, D. Zahrieh, E. Mall, B.A.

Gusterson, K.N. Price, R.D. Gelber, S.B. Holmberg, J. Lindtner, R. Snyder, B.

Th ürlimann, E. Murray, G. Viale, M. Castiglione- Gertsch, A.S. Caotes and A.

Goldhirsch. South African Society Medical Oncology/South African Society

Clinical Radiation Oncology (SASMO/SASCRO) Congress. Cape Town

CTICC, February 2009

Multi-Disciplinary Clinics in Oncology/Breast Cancer E.Murray Surgical

Oncology Congress, Johannesburg. February 2009

A post-mastectomy radiotherapy technique for centres with limited resources . J. Hough, E. Murray, K. Botha. South African Society Medical

Oncology/South African Society Clinical Radiation Oncology

(SASMO/SASCRO) Congress,

Drakensberg, April 2007

Invited speaker: The treatment of breast cancer in Africa

IAEA Nobel Peace Prize Event, UCT Breakwater Lodge, Cape Town

December 2006.

Site of the primary tumour has a prognostic role in operable breast cancer: The IBCSG experience.

Presented by E. Murray for the IBCSG

M. Colleoni, D. Zahrieh, R.D. Gelber, S.B. Holmberg, J.E. Mattson,

C-M Rudenstam, J. Lindtner, D. Eržen, R. Snyder, J. Collins, M.F. Fey,

B. Thürlimann, D. Crivellari, E. Murray, C. Mendiola, O. Pagani,

M. Castiglione-Gertsch, A.S.Coates, K. Price, A. Goldhirsch for the

International Breast Cancer Study Group. SASMO/SASCRO, Wild Coast

Sun, South Africa, 2005

Invited speaker: The management of locally advanced breast cancer.

24 th Biennial Congress of The Association of Surgeons of SA, Cape Town

Convention Centre, August 2004

Primary male breast cancer (Poster presentation) M. Selepe, C. Honnibal,

D. Dent, D. Werner, E. Murray, P. Hall PATH Splash 2004 Congress,

Stellenbosch, 2004.

Poster: Neutron versus Photon Radiotherapy in Locally Advanced

Breast Cancer (LABC) With or Without Metastases.

E.M. Murray, I.D.

Werner, G. Schmitt, C. Stannard, A. Gudgeon, J. Wilson, J. Harris, S.

Fredericks, E. McEvoy, E. Nel 11 th SASMO/SASCRO Congress,

Bloemfontein March 2003.

CMF vs CMF and Tamoxifen in Post Menopausal Lymph Node Negative

Breast Cancer.

Presented by E. Murray for the IBCSG

11 th SASMO/SASCRO Congress, Bloemfontein March 2003.

Invited speaker: Breast cancer: Medical and Radiation Oncology in

Developing Countries with particular emphasis on locally advanced breast cancer.

Pre-Congress Workshop: Congress of The South African

Society of Nuclear Medicine, 3 December, Stellenbosch, 2002

Medical and Radiation Oncology for Breast Cancer in Developing

2001

2001

2000

2000

2000

1998

1997

17.

18.

1997 24.

1997 25.

1996

19.

20.

21.

22.

23.

26.

Countries/Locally Advanced Breast Cancer. E. Murray

SASMO/SASCRO Congress, Muldersdrift, September 2001.

Invited speaker: Postmastectomy radiotherapy .

Plastic Surgery National Registrars’ Symposium, University of Cape Town.

July 2001.

Skin sparing mastectomy and immediate reconstruction for breast cancer: oncological considerations . W. Ddamulira, E. Panieri, D.A.

Hudson, D.M. Dent, E. Murray, D. Werner. Surgical Research Society (SRS)

Conference, Johannesburg. July 2001

Neutron therapy at the National Accelerator Centre . C. Stannard,

F. Vernimmen, E. Murray, L. Van Wijk, J. Harris, R Abratt, V. Levin, E. Mills,

J. Wilson 1 st International Congress Of The South African Radiobiology

Society, Stellenbosch. December 2000.

Breast reconstruction after mastectomy: Who are candidates?

E. Panieri, D. Lazarus, D. Hudson, E. Murray, D.M. Dent. ASSA Congress

Port Elizabeth, South Africa. November 2000

Poster – When benign becomes malignant: A breast odyssey.

I.D.Werner, N Simons, D A Taylor, E M Murray, J Apffelstaedt Society of

Radiographers Congress, Cape Town, September, 2000.

Current trials at the National Accelerator Centre.

C. Stannard,

F. Vernimmen, L. Van Wijk, D. Werner, E. Murray, S. Fredericks.

SASMO/SASCRO Congress, Cape Town, October 1998.

Phase II study of I.V. Navelbine (NVB) and Doxorubicin (DOX) in previously untreated advanced breast cancer (ABC). D. Vorobiof,

L. Goedhals, P. Barnardt, A. Gudgeon, A. Van Der Merwe, L. Smith,

E. Murray, D. Pretorius, P. Bassompierre, E. Bergonzoli, F.M. Delgado,

I. Lepape, J.P. Burillon, S. Le Couturier. SASMO/SASCRO Congress,

Durban, March 1997

8 years of particle therapy at the NationalAccelerator Centre.

C. Stannard, J. Wilson, F. Vernimmen, D. Jones,N. Schreuder, J. Symons,

E. Murray, L. Van Wijk, C. Johnson, R. Abratt. SASMO/SASCRO Congress,

Durban, March 1997

Trial of photons versus neutrons in locally advanced breast cancer.

I.D. Werner, E.M. Murray, C.A. Gudgeon, C.E. Stannard, A. Visser.

Combined Congress SASMO/SASCRO Durban, March 1997.

Invited Speaker: Treatment Options in Breast Cancer. Regional Training

Course on Techniques and Dosimetry in Interstitial Brachytherapy.

International Atomic Energy Agency in Collaboration with the Departments of

Radiation Oncology and Medical Physics, Groote Schuur Hospital and the

University of Cape Town. April 1996.

1995 27.

1995 28.

Postradiation sarcomas: A review of 2O cases.

E.M. Murray, E. Greeff,

D. Taylor, M. Garb, I.D. Werner. Combined Congress Of The South African

Society of Medical Oncologists SASMO/SASCRO Congress, Thaba 'Nchu,

September 1995. Awarded Congress poster prize .

The National Neutron Therapy Programme.

C. Stannard, F. Vernimmen,

L. van Wijk, S. Brennan, A.M. Visser, C. Johnson, J. Wilson, V. Levin,

E. Mills, A. Alberts, D. Werner, B. Smit, G. Schmitt, D. Kranold, E. Murray,

A. Gudgeon, N. Bental, R. Abratt, J. Kiley, A. van der Merwe, R. Keuler,

B. L. Goedhals, H. Krawitz, B. Donde, S. Bairston, D. Friediger, A. Dreyer,

V. Reddi, M. Morgan SASMO/SASCRO Congress, Thaba 'Nchu. September

1995.

1995 29. Breast carcinoma at Groote Schuur Hospital. A 25-year retrospective.

I.D. Werner, A. Gudgeon, E. Murray, E. Timotheus. SASMO/SASCRO

Congress, Thaba 'Nchu, September 1995.

1995 30. Invited Speaker: Breast Symposium, Constantiaberg Hospital, Cape Town,

May 1995. Presentation on Treatment of Metastatic Disease .

1994 31. Invited Lecture: New trends in therapy . E. Murray, A. Gudgeon, D.M. Dent.

University of Cape Town Extra-Mural Course 1994, University of Cape Town.

May 1994.

1990 32. Irradiation induced malignancy after radiotherapy for breast carcinoma.

E. Murray, E. Greeff, M. Hanly, C. A. Gudgeon, D.M. Dent, E.A. Hacking.

3th National Congress of The South African Society of Radiotherapists, Wild

Coast Sun, Transkei. April 1990.

5.3 Presentations at Refresher/Educational courses

2006 Invited speaker: The treatment of breast cancer in Africa

IAEA Nobel Peace Prize Event, UCT Breakwater Lodge, Cape Town

2001 Invited speaker: Postmastectomy radiotherapy .

Plastic Surgery National Registrars’ Symposium

University of Cape Town.

1996 Invited Speaker: Treatment Options in Breast Cancer . Regional Training

Course on Techniques and Dosimetry in Interstitial Brachytherapy.

International Atomic Energy Agency in Collaboration with the Departments of

Radiation Oncology and Medical Physics, Groote Schuur Hospital and the

University of Cape Town.

Download